“Today’s commercial marijuana products are associated with depression, suicidality, IQ loss and most recently psychosis and schizophrenia, especially for young people,” said Smart Approaches to Marijuana Action President Dr. Kevin Sabet in a Sept. 1 news release from the office of Rep. Chuck Edwards.
Read here.